Literature DB >> 28455852

Practical application of in silico fragmentation based residue screening with ion mobility high-resolution mass spectrometry.

Anton Kaufmann1, Patrick Butcher1, Kathry Maden1, Stephan Walker1, Mirjam Widmer1.   

Abstract

RATIONALE: A screening concept for residues in complex matrices based on liquid chromatography coupled to ion mobility high-resolution mass spectrometry LC/IMS-HRMS is presented. The comprehensive four-dimensional data (chromatographic retention time, drift time, mass-to-charge and ion abundance) obtained in data-independent acquisition (DIA) mode was used for data mining. An in silico fragmenter utilizing a molecular structure database was used for suspect screening, instead of targeted screening with reference substances.
METHODS: The utilized data-independent acquisition mode relies on the MSE concept; where two constantly alternating HRMS scans (low and high fragmentation energy) are acquired. Peak deconvolution and drift time alignment of ions from the low (precursor ion) and high (product ion) energy scan result in relatively clean product ion spectra. A bond dissociation in silico fragmenter (MassFragment) supplied with mol files of compounds of interest was used to explain the observed product ions of each extracted candidate component (chromatographic peak).
RESULTS: Two complex matrices (fish and bovine liver extract) were fortified with 98 veterinary drugs. Out of 98 screened compounds 94 could be detected with the in silico based screening approach. The high correlation among drift time and m/z value of equally charged ions was utilized for an orthogonal filtration (ranking). Such an orthogonal ion mobility based filter removes multiply charged ions (e.g. peptides and proteins from the matrix) as well as noise and artefacts. Most significantly, this filtration dramatically reduces false positive findings but hardly increases false negative findings.
CONCLUSIONS: The proposed screening approach may offer new possibilities for applications where reference compounds are hardly or not at all commercially available. Such areas may be the analysis of metabolites of drugs, pyrrolizidine alkaloids, marine toxins, derivatives of sildenafil or novel designer drugs (new psychoactive substances).
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Year:  2017        PMID: 28455852     DOI: 10.1002/rcm.7890

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  4 in total

1.  Using In Silico Fragmentation to Improve Routine Residue Screening in Complex Matrices.

Authors:  Anton Kaufmann; Patrick Butcher; Kathryn Maden; Stephan Walker; Mirjam Widmer
Journal:  J Am Soc Mass Spectrom       Date:  2017-09-12       Impact factor: 3.109

2.  Expanding Urinary Metabolite Annotation through Integrated Mass Spectral Similarity Networking.

Authors:  Fausto Carnevale Neto; Daniel Raftery
Journal:  Anal Chem       Date:  2021-08-26       Impact factor: 8.008

3.  In Silico Collision Cross Section Calculations to Aid Metabolite Annotation.

Authors:  Susanta Das; Kiyoto Aramis Tanemura; Laleh Dinpazhoh; Mithony Keng; Christina Schumm; Lydia Leahy; Carter K Asef; Markace Rainey; Arthur S Edison; Facundo M Fernández; Kenneth M Merz
Journal:  J Am Soc Mass Spectrom       Date:  2022-04-04       Impact factor: 3.262

Review 4.  Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography-mass spectrometry.

Authors:  Yang Yu; Changliang Yao; De-An Guo
Journal:  Acta Pharm Sin B       Date:  2021-02-26       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.